FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine. Substance of the inventions involves monolamellar liposomes of the size of 100-200 nm consisting of a mixture containing 1 weight fraction of tetramannosyl-tri-L-lysine-diopeoyl glycerol and 99 weight fraction of 2,3-dipalmitole-Sn-glycero-phosphatidylcholine, and containing three oligopeptides with their sequence relevant to the sequences of the fragments: 46-62, 124-139 and 147-170 myelin basic protein. What is offered as an agent for multiple sclerosis is a pharmaceutical composition containing monolamellar liposomes as an active ingredient, as well as a method of treating multiple sclerosis involving the introduction of said pharmaceutical composition into the patient.
EFFECT: preparing the liposomes containing oligopeptides - fragments of myelin basic protein, the pharmaceutical composition and developing the method of treating multiple sclerosis.
5 cl, 7 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
INJECTABLE DOSAGE FORM OF OLIGOPEPTIDE PREPARATION FOR TREATING MULTIPLE SCLEROSIS AND METHOD FOR PRODUCING IT | 2010 |
|
RU2561582C2 |
PEPTIDE FROM THE COMPOSITION OF THE IMMUNOGLOBULIN HUMAN HEAVY CHAIN, SUITABLE FOR TREATMENT OF MULTIPLE SCLEROSIS | 2016 |
|
RU2646817C1 |
LIPOSOMES CONTAINING OLIGOPEPTIDE FRAGMENTS OF MYELIN BASIC PROTEIN, PHARMACEUTICAL COMPOSITION AND METHOD FOR MULTIPLE SCLEROSIS TREATMENT | 2013 |
|
RU2639497C2 |
ACTH-LIKE PEPTIDE WITH IMMUNOSUPRESSOR FUNCTION | 2017 |
|
RU2681317C1 |
LIPOSOMAL COMPOSITION FOR APPLICATION IN PERITONEAL DIALYSIS | 2013 |
|
RU2609860C2 |
LIPOSOMAL DRUG FOR USE IN THE TREATMENT OF MALIGNANT NEOPLASM | 2017 |
|
RU2756755C2 |
DOSAGE FORM OF SPECIFIC IMMUNOBIOLOGICAL MEDICINE FOR TREATING AND PREVENTING HIV INFECTION AND PREPARATION METHOD THEREOF | 2014 |
|
RU2600031C2 |
PHARMACEUTICAL COMPOSITIONS TO REDUCE COMPLICATIONS OF OCULAR STEROID | 2013 |
|
RU2660585C2 |
PROLIPOSOMAL POWDER FOR INHALATION | 1995 |
|
RU2162689C2 |
ANESTHETIC COMPOSITIONS WITH DELAYED RELEASE AND METHODS FOR THEIR PREPARATION | 2018 |
|
RU2791481C2 |
Authors
Dates
2012-04-27—Published
2009-11-30—Filed